News Focus
News Focus
Post# of 257660
Next 10
Followers 69
Posts 4517
Boards Moderated 0
Alias Born 12/13/2009

Re: bladerunner1717 post# 149464

Thursday, 09/27/2012 12:57:06 AM

Thursday, September 27, 2012 12:57:06 AM

Post# of 257660
Yes, in the future. But more immediate competition is Avastin, which met primary endpoint PFS in PROC regardless of folate receptor from a ph3 study earlier this year. They are in discussion with EMA Regarding filing MAA. They are not planning to file in US yet because they are waiting for OS next year.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today